CN Stock MarketDetailed Quotes

002900 Harbin Medisan Pharmaceutical

Watchlist

9.40
-0.27-2.79%

Market Closed Jan 3 15:00 CST

2.97BMarket Cap54.97P/E (TTM)

Harbin Medisan Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-26.94%765.3M

-34.20%776.11M

-13.85%1.07B

-17.58%991.16M

-12.60%1.05B

3.09%1.18B

3.20%1.24B

126.99%1.2B

298.31%1.2B

299.30%1.14B

Transactional financial assets

-10.03%75.33M

65.94%110.69M

11.92%91.44M

-36.71%57.75M

2.70%83.73M

-29.63%66.71M

-30.87%81.7M

-84.31%91.25M

-86.03%81.53M

-86.38%94.79M

Notes receivable and accounts receivable

18.94%152.99M

10.44%123.59M

-46.39%77.7M

-18.65%98.23M

12.98%128.63M

-18.01%111.91M

5.67%144.94M

-5.34%120.75M

-12.58%113.85M

-6.31%136.48M

-Notes receivable

-0.37%3.63M

-7.96%3.47M

-34.76%3.64M

-63.34%3.23M

--3.64M

--3.77M

--5.58M

--8.8M

----

-Accounts receivable

19.50%149.37M

11.08%120.13M

-46.86%74.06M

-15.14%95M

9.78%124.99M

-20.76%108.14M

1.61%139.36M

-12.24%111.95M

-12.58%113.85M

-6.31%136.48M

Other receivables (including interest and dividends)

50.17%1.4M

64.38%1.36M

15.60%2.71M

74.26%1.73M

-57.46%929.19K

82.53%825.51K

-9.32%2.35M

55.42%991.69K

-20.30%2.18M

-80.80%452.26K

-Dividend receivable

----

-13.83%1.19M

----

2.64%1.38M

----

--1.25M

----

-Other receivable

----

64.38%1.36M

----

82.53%825.51K

----

55.42%991.69K

----

-80.80%452.26K

Advance payment

-2.82%65.11M

67.79%67.76M

11.58%63.32M

28.38%49.38M

81.78%67M

39.48%40.38M

92.30%56.75M

140.22%38.46M

95.69%36.86M

24.37%28.95M

Inventories

32.55%247.82M

47.87%254.98M

36.85%233M

29.55%208.79M

19.94%186.97M

17.08%172.44M

16.58%170.25M

2.95%161.16M

1.58%155.88M

-0.92%147.28M

Receivable financing

-74.14%2.75M

-50.39%3.28M

98.16%4.41M

-67.92%1.23M

20.63%10.65M

-32.12%6.61M

-70.70%2.22M

-29.01%3.85M

109.09%8.83M

162.25%9.74M

Other current assets

249.14%30.42M

457.68%33.44M

367.16%27.65M

519.20%28.16M

214.74%8.71M

339.97%6M

-33.12%5.92M

-52.13%4.55M

-45.29%2.77M

-77.50%1.36M

Total current assets

-12.58%1.34B

-13.45%1.37B

-7.95%1.57B

-11.53%1.44B

-4.14%1.53B

1.35%1.58B

3.19%1.7B

13.77%1.62B

33.47%1.6B

19.10%1.56B

Non Current assets

Long-term equity investment

2.06%713.81M

6.24%706.01M

9.28%715.81M

9.60%708.99M

9.77%699.4M

6.80%664.54M

6.99%655.02M

7.01%646.87M

5.22%637.15M

4.30%622.22M

Long term receivable account

--15M

----

--0

----

Fixed assets

----

-3.99%725.48M

----

-3.44%755.62M

----

-5.62%776.72M

----

5.18%782.5M

Constru in process

----

163.10%418.78M

----

221.66%159.17M

----

29.31%58.19M

----

-62.78%49.48M

Construction materials

----

--0

----

-52.16%151.28K

----

Intangible assets

9.31%119.74M

22.20%116.44M

86.36%111.93M

85.54%113.37M

83.87%109.54M

57.37%95.28M

-2.38%60.06M

-2.24%61.1M

-6.16%59.57M

-6.07%60.55M

Development expenditure

28.24%34.67M

88.10%33.52M

75.28%27.87M

163.45%27.84M

1,173.70%27.04M

--17.82M

--15.9M

--10.57M

--2.12M

----

Goodwill

0.00%1.34M

167.97%1.34M

-85.80%1.34M

-94.70%500K

0.00%9.44M

Long deferred expense

14.10%26.19M

11.86%27.26M

8.25%28.58M

8.23%30.12M

162.44%22.96M

159.32%24.37M

162.89%26.41M

160.25%27.83M

-23.61%8.75M

-24.22%9.4M

Deferred tax assets

-8.78%22.18M

-4.73%23.57M

-2.86%23.09M

-6.47%23.08M

-5.86%24.31M

1.66%24.74M

-13.61%23.77M

-4.52%24.68M

7.86%25.83M

9.50%24.33M

Usufruct assets

-9.57%40.03M

-10.24%42.14M

-0.87%44.8M

0.13%47.45M

-36.97%44.26M

-10.11%46.94M

-17.28%45.2M

-16.93%47.39M

18.29%70.22M

-14.36%52.22M

Other non current assets

--28.06M

--36.92M

--34.36M

--20.22M

----

Total non current assets

16.49%2.21B

19.98%2.15B

22.01%2.06B

21.32%2.01B

15.42%1.9B

11.11%1.79B

3.80%1.69B

0.96%1.65B

-10.55%1.65B

-12.64%1.61B

Total assets

3.51%3.56B

4.28%3.52B

6.96%3.62B

5.04%3.44B

5.78%3.43B

6.30%3.37B

3.49%3.39B

6.92%3.28B

6.81%3.25B

0.56%3.17B

Liabilities

Current liabilities

Short term loan

109.27%575.96M

118.84%580.34M

59.24%430.36M

24.99%275.27M

-1.77%275.23M

-5.39%265.19M

-6.81%270.26M

-18.52%220.22M

33.42%280.19M

12.11%280.29M

Notes payable and accounts payable

0.25%173.6M

2.45%174.07M

31.78%178.82M

50.72%182.13M

75.87%173.18M

98.36%169.9M

49.12%135.7M

14.91%120.84M

4.68%98.47M

-10.13%85.66M

-Notes payable

-17.17%49.85M

-5.05%59.74M

-6.97%50.89M

59.02%51.79M

217.66%60.18M

281.72%62.92M

260.40%54.7M

113.64%32.57M

11.63%18.94M

42.31%16.48M

-Accounts payable

9.52%123.76M

6.86%114.33M

57.95%127.93M

47.66%130.34M

42.09%112.99M

54.67%106.99M

6.82%80.99M

-1.83%88.27M

3.15%79.52M

-17.38%69.17M

Contract liabilities

-61.61%13.58M

-34.70%14.47M

-31.58%19.46M

-21.07%43.25M

176.14%35.37M

102.52%22.16M

109.63%28.45M

160.12%54.79M

-10.33%12.81M

-27.89%10.94M

Salaries payable

12.42%12.53M

13.18%11.87M

-23.79%11.36M

81.67%22.8M

6.46%11.15M

-2.80%10.49M

-3.37%14.9M

-47.40%12.55M

29.11%10.47M

36.54%10.79M

Taxs payable

71.15%8.08M

-78.94%1.38M

-58.66%4.08M

-74.69%3.08M

-62.23%4.72M

-29.69%6.57M

-4.45%9.86M

8.96%12.15M

39.38%12.5M

23.71%9.34M

Other payable (including interest and dividends)

-48.71%77.31M

-42.14%93.26M

-46.21%97.77M

-29.15%105.64M

-5.07%150.73M

51.11%161.18M

69.31%181.77M

52.07%149.11M

96.92%158.78M

-13.85%106.66M

-Other payable

----

-42.14%93.26M

----

51.11%161.18M

----

52.07%149.11M

----

7.70%106.66M

Non current liabilities due within one year

-5.92%205.85M

1,534.40%205.89M

3,009.06%405.06M

1,410.00%204.95M

1,481.88%218.81M

208.96%12.6M

194.98%13.03M

200.34%13.57M

--13.83M

--4.08M

Other current liabilities

-34.62%4.77M

-10.30%5M

-48.30%4.44M

-45.36%7.92M

342.52%7.3M

306.99%5.58M

468.84%8.58M

474.09%14.5M

2.48%1.65M

-19.13%1.37M

Total current liabilities

22.27%1.07B

66.19%1.09B

73.77%1.15B

41.37%845.03M

48.88%876.48M

28.39%653.66M

24.17%662.55M

11.39%597.73M

40.95%588.71M

1.53%509.13M

Current liabilities

Long term loan

----

-75.41%104.39M

-80.38%82.63M

----

-49.10%210.96M

0.83%424.48M

0.80%421.1M

103.95%417.78M

105.60%414.5M

133.89%421M

Bonds payable

--124.36M

----

--229.83M

----

Deferred tax liabilities

1.44%130.63M

3.34%130.11M

8.16%134.16M

9.59%132.54M

9.92%128.77M

10.08%125.91M

10.98%124.04M

9.35%120.95M

759.39%117.15M

494.37%114.38M

Long term deferred income

-5.92%75.64M

-6.65%76.38M

-6.72%77.65M

-5.77%79.03M

-5.56%80.4M

-5.31%81.83M

-5.05%83.25M

-5.72%83.86M

-3.23%85.14M

-0.29%86.41M

Lease liabilities

39.29%6.98M

28.44%6.39M

61.29%7.9M

61.98%8.33M

-10.37%5.01M

-20.65%4.97M

-23.46%4.9M

-35.90%5.14M

-57.58%5.59M

-59.34%6.27M

Total non current liabilities

-20.59%337.61M

-50.21%317.27M

-52.26%302.34M

-28.36%449.73M

-31.69%425.15M

1.45%637.19M

1.55%633.29M

52.21%627.74M

96.71%622.38M

108.44%628.06M

Total liabilities

8.27%1.41B

8.73%1.4B

12.18%1.45B

5.65%1.29B

7.48%1.3B

13.51%1.29B

11.98%1.3B

29.13%1.23B

64.98%1.21B

41.66%1.14B

Shareholders equity

Paid-in capital

-0.05%316.39M

-0.07%316.39M

-0.01%316.56M

0.00%316.6M

Capital reserve funds

0.79%1.09B

3.18%1.09B

4.04%1.08B

3.79%1.08B

0.78%1.08B

-1.74%1.05B

-2.78%1.04B

0.00%1.07B

Surplus reserve funds

0.00%158.3M

Retained profit

-1.50%590.24M

-2.59%575.93M

3.58%631.72M

7.36%612.93M

6.65%599.2M

5.39%591.25M

-4.48%609.88M

-10.75%570.91M

-32.18%561.85M

-35.88%561.01M

Less:Treasury stock

-56.52%13.36M

-37.54%29.54M

-38.20%29.54M

-64.18%30.72M

-44.87%47.29M

-44.28%47.79M

0.00%85.77M

Shareholders equity without minority interests

0.79%2.14B

1.72%2.11B

3.94%2.16B

4.88%2.14B

4.98%2.12B

2.47%2.07B

-0.97%2.08B

-2.88%2.04B

-11.64%2.02B

-13.44%2.02B

Minority interests

-46.27%4.65M

-42.68%5.48M

-39.15%6.36M

-31.67%7.73M

-29.65%8.65M

-27.98%9.56M

-27.33%10.45M

-24.68%11.32M

-21.09%12.3M

-16.65%13.27M

Total shareholder equity

0.60%2.15B

1.52%2.11B

3.73%2.17B

4.68%2.15B

4.77%2.13B

2.28%2.08B

-1.15%2.09B

-3.04%2.05B

-11.70%2.04B

-13.46%2.04B

Total liabilityies and equity

3.51%3.56B

4.28%3.52B

6.96%3.62B

5.04%3.44B

5.78%3.43B

6.30%3.37B

3.49%3.39B

6.92%3.28B

6.81%3.25B

0.56%3.17B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-26.94%765.3M	-34.20%776.11M	-13.85%1.07B	-17.58%991.16M	-12.60%1.05B	3.09%1.18B	3.20%1.24B	126.99%1.2B	298.31%1.2B	299.30%1.14B
Transactional financial assets	-10.03%75.33M	65.94%110.69M	11.92%91.44M	-36.71%57.75M	2.70%83.73M	-29.63%66.71M	-30.87%81.7M	-84.31%91.25M	-86.03%81.53M	-86.38%94.79M
Notes receivable and accounts receivable	18.94%152.99M	10.44%123.59M	-46.39%77.7M	-18.65%98.23M	12.98%128.63M	-18.01%111.91M	5.67%144.94M	-5.34%120.75M	-12.58%113.85M	-6.31%136.48M
-Notes receivable	-0.37%3.63M	-7.96%3.47M	-34.76%3.64M	-63.34%3.23M	--3.64M	--3.77M	--5.58M	--8.8M	----	----
-Accounts receivable	19.50%149.37M	11.08%120.13M	-46.86%74.06M	-15.14%95M	9.78%124.99M	-20.76%108.14M	1.61%139.36M	-12.24%111.95M	-12.58%113.85M	-6.31%136.48M
Other receivables (including interest and dividends)	50.17%1.4M	64.38%1.36M	15.60%2.71M	74.26%1.73M	-57.46%929.19K	82.53%825.51K	-9.32%2.35M	55.42%991.69K	-20.30%2.18M	-80.80%452.26K
-Dividend receivable	----	----	-13.83%1.19M	----	----	----	2.64%1.38M	----	--1.25M	----
-Other receivable	----	64.38%1.36M	----	----	----	82.53%825.51K	----	55.42%991.69K	----	-80.80%452.26K
Advance payment	-2.82%65.11M	67.79%67.76M	11.58%63.32M	28.38%49.38M	81.78%67M	39.48%40.38M	92.30%56.75M	140.22%38.46M	95.69%36.86M	24.37%28.95M
Inventories	32.55%247.82M	47.87%254.98M	36.85%233M	29.55%208.79M	19.94%186.97M	17.08%172.44M	16.58%170.25M	2.95%161.16M	1.58%155.88M	-0.92%147.28M
Receivable financing	-74.14%2.75M	-50.39%3.28M	98.16%4.41M	-67.92%1.23M	20.63%10.65M	-32.12%6.61M	-70.70%2.22M	-29.01%3.85M	109.09%8.83M	162.25%9.74M
Other current assets	249.14%30.42M	457.68%33.44M	367.16%27.65M	519.20%28.16M	214.74%8.71M	339.97%6M	-33.12%5.92M	-52.13%4.55M	-45.29%2.77M	-77.50%1.36M
Total current assets	-12.58%1.34B	-13.45%1.37B	-7.95%1.57B	-11.53%1.44B	-4.14%1.53B	1.35%1.58B	3.19%1.7B	13.77%1.62B	33.47%1.6B	19.10%1.56B
Non Current assets
Long-term equity investment	2.06%713.81M	6.24%706.01M	9.28%715.81M	9.60%708.99M	9.77%699.4M	6.80%664.54M	6.99%655.02M	7.01%646.87M	5.22%637.15M	4.30%622.22M
Long term receivable account	--15M	--15M	----	--0	----	----	----	----	----	----
Fixed assets	----	-3.99%725.48M	----	----	----	-3.44%755.62M	----	-5.62%776.72M	----	5.18%782.5M
Constru in process	----	163.10%418.78M	----	----	----	221.66%159.17M	----	29.31%58.19M	----	-62.78%49.48M
Construction materials	----	----	----	----	----	--0	----	-52.16%151.28K	----	----
Intangible assets	9.31%119.74M	22.20%116.44M	86.36%111.93M	85.54%113.37M	83.87%109.54M	57.37%95.28M	-2.38%60.06M	-2.24%61.1M	-6.16%59.57M	-6.07%60.55M
Development expenditure	28.24%34.67M	88.10%33.52M	75.28%27.87M	163.45%27.84M	1,173.70%27.04M	--17.82M	--15.9M	--10.57M	--2.12M	----
Goodwill	0.00%1.34M	167.97%1.34M	167.97%1.34M	167.97%1.34M	-85.80%1.34M	-94.70%500K	-94.70%500K	-94.70%500K	0.00%9.44M	0.00%9.44M
Long deferred expense	14.10%26.19M	11.86%27.26M	8.25%28.58M	8.23%30.12M	162.44%22.96M	159.32%24.37M	162.89%26.41M	160.25%27.83M	-23.61%8.75M	-24.22%9.4M
Deferred tax assets	-8.78%22.18M	-4.73%23.57M	-2.86%23.09M	-6.47%23.08M	-5.86%24.31M	1.66%24.74M	-13.61%23.77M	-4.52%24.68M	7.86%25.83M	9.50%24.33M
Usufruct assets	-9.57%40.03M	-10.24%42.14M	-0.87%44.8M	0.13%47.45M	-36.97%44.26M	-10.11%46.94M	-17.28%45.2M	-16.93%47.39M	18.29%70.22M	-14.36%52.22M
Other non current assets	--28.06M	--36.92M	--34.36M	--20.22M	----	----	----	----	----	----
Total non current assets	16.49%2.21B	19.98%2.15B	22.01%2.06B	21.32%2.01B	15.42%1.9B	11.11%1.79B	3.80%1.69B	0.96%1.65B	-10.55%1.65B	-12.64%1.61B
Total assets	3.51%3.56B	4.28%3.52B	6.96%3.62B	5.04%3.44B	5.78%3.43B	6.30%3.37B	3.49%3.39B	6.92%3.28B	6.81%3.25B	0.56%3.17B
Liabilities
Current liabilities
Short term loan	109.27%575.96M	118.84%580.34M	59.24%430.36M	24.99%275.27M	-1.77%275.23M	-5.39%265.19M	-6.81%270.26M	-18.52%220.22M	33.42%280.19M	12.11%280.29M
Notes payable and accounts payable	0.25%173.6M	2.45%174.07M	31.78%178.82M	50.72%182.13M	75.87%173.18M	98.36%169.9M	49.12%135.7M	14.91%120.84M	4.68%98.47M	-10.13%85.66M
-Notes payable	-17.17%49.85M	-5.05%59.74M	-6.97%50.89M	59.02%51.79M	217.66%60.18M	281.72%62.92M	260.40%54.7M	113.64%32.57M	11.63%18.94M	42.31%16.48M
-Accounts payable	9.52%123.76M	6.86%114.33M	57.95%127.93M	47.66%130.34M	42.09%112.99M	54.67%106.99M	6.82%80.99M	-1.83%88.27M	3.15%79.52M	-17.38%69.17M
Contract liabilities	-61.61%13.58M	-34.70%14.47M	-31.58%19.46M	-21.07%43.25M	176.14%35.37M	102.52%22.16M	109.63%28.45M	160.12%54.79M	-10.33%12.81M	-27.89%10.94M
Salaries payable	12.42%12.53M	13.18%11.87M	-23.79%11.36M	81.67%22.8M	6.46%11.15M	-2.80%10.49M	-3.37%14.9M	-47.40%12.55M	29.11%10.47M	36.54%10.79M
Taxs payable	71.15%8.08M	-78.94%1.38M	-58.66%4.08M	-74.69%3.08M	-62.23%4.72M	-29.69%6.57M	-4.45%9.86M	8.96%12.15M	39.38%12.5M	23.71%9.34M
Other payable (including interest and dividends)	-48.71%77.31M	-42.14%93.26M	-46.21%97.77M	-29.15%105.64M	-5.07%150.73M	51.11%161.18M	69.31%181.77M	52.07%149.11M	96.92%158.78M	-13.85%106.66M
-Other payable	----	-42.14%93.26M	----	----	----	51.11%161.18M	----	52.07%149.11M	----	7.70%106.66M
Non current liabilities due within one year	-5.92%205.85M	1,534.40%205.89M	3,009.06%405.06M	1,410.00%204.95M	1,481.88%218.81M	208.96%12.6M	194.98%13.03M	200.34%13.57M	--13.83M	--4.08M
Other current liabilities	-34.62%4.77M	-10.30%5M	-48.30%4.44M	-45.36%7.92M	342.52%7.3M	306.99%5.58M	468.84%8.58M	474.09%14.5M	2.48%1.65M	-19.13%1.37M
Total current liabilities	22.27%1.07B	66.19%1.09B	73.77%1.15B	41.37%845.03M	48.88%876.48M	28.39%653.66M	24.17%662.55M	11.39%597.73M	40.95%588.71M	1.53%509.13M
Current liabilities
Long term loan	----	-75.41%104.39M	-80.38%82.63M	----	-49.10%210.96M	0.83%424.48M	0.80%421.1M	103.95%417.78M	105.60%414.5M	133.89%421M
Bonds payable	--124.36M	----	----	--229.83M	----	----	----	----	----	----
Deferred tax liabilities	1.44%130.63M	3.34%130.11M	8.16%134.16M	9.59%132.54M	9.92%128.77M	10.08%125.91M	10.98%124.04M	9.35%120.95M	759.39%117.15M	494.37%114.38M
Long term deferred income	-5.92%75.64M	-6.65%76.38M	-6.72%77.65M	-5.77%79.03M	-5.56%80.4M	-5.31%81.83M	-5.05%83.25M	-5.72%83.86M	-3.23%85.14M	-0.29%86.41M
Lease liabilities	39.29%6.98M	28.44%6.39M	61.29%7.9M	61.98%8.33M	-10.37%5.01M	-20.65%4.97M	-23.46%4.9M	-35.90%5.14M	-57.58%5.59M	-59.34%6.27M
Total non current liabilities	-20.59%337.61M	-50.21%317.27M	-52.26%302.34M	-28.36%449.73M	-31.69%425.15M	1.45%637.19M	1.55%633.29M	52.21%627.74M	96.71%622.38M	108.44%628.06M
Total liabilities	8.27%1.41B	8.73%1.4B	12.18%1.45B	5.65%1.29B	7.48%1.3B	13.51%1.29B	11.98%1.3B	29.13%1.23B	64.98%1.21B	41.66%1.14B
Shareholders equity
Paid-in capital	-0.05%316.39M	-0.05%316.39M	-0.07%316.39M	-0.07%316.39M	-0.01%316.56M	-0.01%316.56M	0.00%316.6M	0.00%316.6M	0.00%316.6M	0.00%316.6M
Capital reserve funds	0.79%1.09B	3.18%1.09B	4.04%1.08B	3.79%1.08B	0.78%1.08B	-1.74%1.05B	-2.78%1.04B	-2.78%1.04B	0.00%1.07B	0.00%1.07B
Surplus reserve funds	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M	0.00%158.3M
Retained profit	-1.50%590.24M	-2.59%575.93M	3.58%631.72M	7.36%612.93M	6.65%599.2M	5.39%591.25M	-4.48%609.88M	-10.75%570.91M	-32.18%561.85M	-35.88%561.01M
Less:Treasury stock	-56.52%13.36M	-37.54%29.54M	-38.20%29.54M	-38.20%29.54M	-64.18%30.72M	-44.87%47.29M	-44.28%47.79M	-44.28%47.79M	0.00%85.77M	0.00%85.77M
Shareholders equity without minority interests	0.79%2.14B	1.72%2.11B	3.94%2.16B	4.88%2.14B	4.98%2.12B	2.47%2.07B	-0.97%2.08B	-2.88%2.04B	-11.64%2.02B	-13.44%2.02B
Minority interests	-46.27%4.65M	-42.68%5.48M	-39.15%6.36M	-31.67%7.73M	-29.65%8.65M	-27.98%9.56M	-27.33%10.45M	-24.68%11.32M	-21.09%12.3M	-16.65%13.27M
Total shareholder equity	0.60%2.15B	1.52%2.11B	3.73%2.17B	4.68%2.15B	4.77%2.13B	2.28%2.08B	-1.15%2.09B	-3.04%2.05B	-11.70%2.04B	-13.46%2.04B
Total liabilityies and equity	3.51%3.56B	4.28%3.52B	6.96%3.62B	5.04%3.44B	5.78%3.43B	6.30%3.37B	3.49%3.39B	6.92%3.28B	6.81%3.25B	0.56%3.17B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)	--	--	--	ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

002900 Harbin Medisan Pharmaceutical

Harbin Medisan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow